Gentamicin: Clinical Trials

15 trials of Gentamicin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 2 recruiting, 2 terminated. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Completed 6, Unknown 3, Recruiting 2, Terminated 2, Withdrawn 2

Follow Gentamicin: new trials by email Literature Review of Gentamicin trials Research Report on Gentamicin

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravesical Gentamicin to Prevent Recurrent UTI
Gentamicin, Nitrofurantoin - Recurrent Uti
Phase 4CompletedWomen and Infants Hospital of Rhode Island202025-04-282026-04-15
Gentamicin Bladder Instillation on CAUTI
Gentamicin - Catheter Infection
Phase 4RecruitingSt. Joseph's Hospital and Medical Center, Phoenix4002023-10-092025-07-11
Gentamicin Open Tibia Study
Gentamicin, normal Saline - Fracture Open Tibia
Phase 4RecruitingUniversity of California, San Francisco8902022-09-012026-09-10
INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI
Nitrofurantoin, Gentamicin - Urinary Tract Infections
Phase 4WithdrawnMayo Clinic2017-06-282019-06-06
Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
Gentamicin - Vestibular Schwannoma
Phase 4WithdrawnLund University2015-04-012020-09-11
A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])
nitrofurantoin monohydrate/macrocrystalline capsules, ampicillin, gentamicin - Nephrolithiasis, Urinary Tract Infections
Phase 4CompletedUniversity of California, San Diego862015-03-012019-08-22
Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.
Gentamicin - Renal Failure Chronic Requiring Hemodialysis
Phase 4TerminatedUniversity Hospital, Limoges242013-10-012020-07-17
Gentamicin Bladder Instillation Trial
Gentamicin, Placebo - Urinary Tract Infections
Phase 4UnknownGillette Children's Specialty Healthcare242013-05-012015-04-09
Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Ciprofloxacin, trimethoprim-sulfamethoxazole, cefuroxime - Infection
Phase 4CompletedNorthwestern University5632012-08-012019-06-25
Effectiveness of Topical Antibiotic Prophylaxis in Inguinal Hernia Repair
Gentamicin and cefazolin, Cefazolin, Gentamicin - Inguinal Hernia
Phase 4CompletedDiskapi Teaching and Research Hospital2762011-01-012014-12-29
Efficacy of Combination Therapies for Gonorrhea Treatment
Azithromycin, Gentamicin, Gemifloxacin - Gonorrhoea
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)6142010-06-012015-08-19
Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)
daptomycin, daptomycin and gentamicin - Infective Endocarditis
Phase 4TerminatedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)242009-02-132021-02-02
Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis
gentamicin, gentamicin cream alternating with mupirocin cream - Rate of Exit Site Infection, Rate of Atypical Mycobacterial Infection
Phase 4UnknownKwong Wah Hospital5002008-09-012008-09-11
Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate
ofloxacin, gentamicin - Infection
Phase 4UnknownHaEmek Medical Center, Israel1602007-06-012007-05-30
Long Term Nebulised Gentamicin in Patients With Bronchiectasis
Gentamicin, Saline - Bronchiectasis
Phase 4CompletedUniversity of Edinburgh602007-05-012010-08-10

Conditions studied

Urinary Tract Infections (4)  ·  Infections (3)  ·  Bacteremia (1)  ·  Bronchiectasis (1)  ·  Endocarditis (1)  ·  Gonorrhea (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Hernia, Inguinal (1)  ·  Inflammation (1)  ·  Nephrolithiasis (1)  ·  Neuroma, Acoustic (1)  ·  Recurrence (1)  ·  Staphylococcal Infections (1)

Sponsors

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)  ·  Diskapi Teaching and Research Hospital (1)  ·  Gillette Children's Specialty Healthcare (1)  ·  HaEmek Medical Center, Israel (1)  ·  Kwong Wah Hospital (1)  ·  Lund University (1)  ·  Mayo Clinic (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Northwestern University (1)  ·  St. Joseph's Hospital and Medical Center, Phoenix (1)  ·  University Hospital, Limoges (1)  ·  University of California, San Diego (1)  ·  University of California, San Francisco (1)  ·  University of Edinburgh (1)  ·  Women and Infants Hospital of Rhode Island (1)

Countries

United States (7)  ·  Canada (1)  ·  France (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  Sweden (1)  ·  Tanzania (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Adam T Hill, MBChB MD (1)  ·  Anthony J Schaeffer, MD (1)  ·  Audrey N Schuetz, MD (1)  ·  Bahattin Bayar, MD (1)  ·  Billy T Haonga, MD (1)  ·  Daniel L Miller, MD MPH (1)  ·  David W Shearer, MD, MPH (1)  ·  Deborah Lightner, MD (1)  ·  Duray Seker, MD (1)  ·  Gaye E Seker, MD (1)  ·  Genady Zelychenko, MD (1)  ·  Gensy MW Tong, MBChB (1)  ·  Hahn Soe-Lin, MD (1)  ·  Hakan Kulacoglu, Professor (1)

Results publications

PMID 17917842, PMID 19574236, PMID 19645909, PMID 20870753, PMID 22027076, PMID 22744718, PMID 25031289, PMID 28592230, PMID 32358683, PMID 37322521

NIH funding

K23AR079044 (1)